Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2002 Oct;40(10):3596-601.
doi: 10.1128/JCM.40.10.3596-3601.2002.

Duration of persistence of gonococcal DNA detected by ligase chain reaction in men and women following recommended therapy for uncomplicated gonorrhea

Affiliations

Duration of persistence of gonococcal DNA detected by ligase chain reaction in men and women following recommended therapy for uncomplicated gonorrhea

Laura H Bachmann et al. J Clin Microbiol. 2002 Oct.

Abstract

Neisseria gonorrhoeae infection remains relatively common in the United States, representing a public health challenge. Ligase chain reaction (LCR) is both highly sensitive and specific for the detection of N. gonorrhoeae in urine and patient-obtained vaginal swab specimens. Because of the LCR test's exquisite sensitivity, it may potentially detect DNA from nonviable organisms following effective therapy, leading to false-positive test results and unnecessary additional treatment. The purpose of the present study was to determine the duration that gonococcal DNA is detectable by LCR following therapy for uncomplicated gonococcal infection. One hundred thirty men and women between the ages of 16 and 50 years presenting to a sexually transmitted disease clinic with urogenital gonorrhea were enrolled. After the standard history was taken and a genital examination was done, the patients were asked to submit either a urine specimen (men) or a urine specimen plus a self-obtained vaginal swab specimen (women) for N. gonorrhoeae testing by LCR at the initial visit and each day during the study period. At enrollment, patients were treated with single doses of ofloxacin, cefixime, or ceftriaxone. The median time to a negative urine LCR test result was 1 day for the men (mean, 1.6 +/- 0.14 days) and 2 days for the women (mean, 1.7 +/- 0.19 days). Among the women the clearance time was significantly longer for vaginal specimens (mean, 2.8 +/- 0.30 days) than for urine specimens (mean, 1.7 +/- 0.11 days). Irrespective of patient gender and specimen type, gonococcal DNA can be expected to be absent from urogenital specimens within 2 weeks following successful therapy.

PubMed Disclaimer

Figures

FIG. 1.
FIG. 1.
Proportion of patients with detectable gonococcal nucleic acids in urine following treatment, by gender.
FIG. 2.
FIG. 2.
Proportion of women with detectable gonococcal nucleic acids following treatment, by site.

References

    1. Bianchi, A., M. Bogard, G. Cessot, J. M. Bohbot, J. E. Malkin, and J. M. Alonso. 1998. Kinetics of Chlamydia trachomatis clearance in patients with azithromycin, as assessed by first void urine testing by PCR and transcription-mediated amplification. Sex. Transm. Dis. 25:366-367. - PubMed
    1. Centers for Disease Control and Prevention. 2001. Sexually transmitted disease surveillance 2000. Centers for Disease Control and Prevention, U.S. Department of Health and Human Services, Atlanta, Ga.
    1. Centers for Diseases Control and Prevention. 1998. 1998 guidelines for the treatment of sexually transmitted diseases. Morb. Mortal. Wkly. Rep. 47:1-116. - PubMed
    1. Ching, S., H. Lee, E. W. Hook III, M. R. Jacobs, and J. Zenilman. 1995. Ligase chain reaction for detection of Neisseria gonorrhoeae in urogenital swabs. J. Clin. Microbiol. 33:3111-3114. - PMC - PubMed
    1. Gaydos, C. A., K. A. Crotchfelt, M. R. Howell, S. Kralian, P. Hauptman, and T. C. Quinn. 1998. Molecular amplification assays to detect chlamydial infections in urine specimens from high school female students and to monitor the persistence of chlamydial DNA after therapy. J. Infect. Dis. 177:417-424. - PubMed